Photo taken from C. Ola Landgren/X
Jul 4, 2024, 03:09
C. Ola Landgren: Highlights in Multiple Myeloma From ASCO and EHA 2024
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“Highlights in Multiple Myeloma From ASCO and EHA 2024. Lots of New Exciting Data. Great For Patients!”
Read further.
Source: C. Ola Landgren/X